CLINICAL_TRIALS
research
· 2026-03-16
Clinical Trial Update: Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging [NA]
Summary
A university-led trial is investigating how alpha-synuclein spreads in Parkinson's disease using blood biomarkers and neuroimaging, with recruitment not yet und…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Pavia | Conditions: Parkinson's Disease (PD), GBA1 Parkinson Disease | NA | Status: NOT_YET_RECRUITING